Quick Answer
INTELLIGENT BIO SOLUTIONS INC. reported Cash and Equivalents of $1.02 million for fiscal year 2025.
INTELLIGENT BIO SOLUTIONS INC. Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2025 | $1.02M | -83.8% |
| 2024 | $6.30M | +310.1% |
| 2023 | $1.54M | -81.3% |
| 2022 | $8.24M | -34.5% |
| 2021 | $12.57M | +2842.8% |
| 2020 | $427.3K | — |
Quarterly Cash and Equivalents
| Quarter Ending | Cash and Equivalents | YoY | QoQ |
|---|---|---|---|
| December 31, 2025 | $740.4K | -67.0% | -55.4% |
| September 30, 2025 | $1.66M | -58.4% | +62.8% |
| June 30, 2025 | $1.02M | -83.8% | -63.7% |
| March 31, 2025 | $2.81M | -70.1% | +25.2% |
| December 31, 2024 | $2.24M | +100.4% | -43.8% |
| September 30, 2024 | $3.99M | +2040.2% | -36.7% |
| June 30, 2024 | $6.30M | +310.1% | -32.9% |
| March 31, 2024 | $9.40M | +312.1% | +739.8% |
- INTELLIGENT BIO SOLUTIONS INC. showed a decrease of -83.8% in Cash and Equivalents compared to the prior fiscal year.
- Over the 2020–2025 period, INTELLIGENT BIO SOLUTIONS INC.’s cash and equivalents has grown by 138.7% (from $427.3 thousand to $1.02 million).
- The most recent figure is from INTELLIGENT BIO SOLUTIONS INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on August 15, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: